Global Next Generation Cancer Diagnostics Market is estimated to be US$ 28746.19 million by 2030 wit

Nisha Shaha18 Apr, 2022Health

The Global Next Generation Cancer Diagnostics Market accounted for US$ 5650.9 Million 2020 and is estimated to be US$ 28,746.19 million by 2030 and is anticipated to register a CAGR of 19.8%. NGS is arguably one of the most significant technological advances in biology in the last 30 years. Medical research has embraced technology because of the genetic nature of cancer, and the cancer sector is at the forefront of these efforts. New discoveries are likely to lead to new diagnostic, prognostic, and therapeutic targets as a result of global efforts to catalogue mutations in a range of cancer forms.